CDMO - Avid Bioservices Inc
IEX Last Trade
10.54
0.180 1.708%
Share volume: 526,295
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.36
0.18
1.74%
View ratios
| Fiscal Date | 2022-07-31 | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 | 2024-04-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2022-09-06 | 2022-12-06 | 2023-03-13 | 2023-06-21 | 2023-09-07 | 2023-12-07 | 2024-04-24 | 2024-07-02 | |
| Assets | |||||||||
| Total Assets | 451.219 M | 441.850 M | 450.430 M | 451.054 M | 442.337 M | 454.642 M | 455.227 M | 336.557 M | |
| Current Assets | 180.635 M | 145.941 M | 132.343 M | 112.451 M | 98.319 M | 104.205 M | 103.589 M | 104.002 M | |
| Inventories | 30.354 M | 39.061 M | 45.102 M | 43.908 M | 40.866 M | 38.583 M | 34.568 M | 30.375 M | |
| Other Current Assets | 9.199 M | 9.008 M | 12.499 M | 11.703 M | 16.346 M | 20.819 M | 19.775 M | 18.877 M | |
| Short Term Investments | 9.199 M | 9.008 M | 12.499 M | 11.703 M | 16.346 M | 20.819 M | 19.775 M | 18.877 M | |
| Total Receivables | 25.945 M | 20.580 M | 14.826 M | 18.298 M | 16.209 M | 13.379 M | 18.538 M | 16.644 M | |
| Current Cash | 115.137 M | 77.292 M | 59.916 M | 38.542 M | 24.898 M | 31.424 M | 30.708 M | 38.106 M | |
| Total Non-current Assets | 270.584 M | 295.909 M | 318.087 M | 338.603 M | 344.018 M | 350.437 M | 351.638 M | 232.555 M | |
| Property Plant Equipment | 114.929 M | 139.386 M | 164.292 M | 177.369 M | 182.299 M | 187.174 M | 187.518 M | 186.514 M | |
| Other Assets | 4.740 M | 4.153 M | 4.402 M | 4.473 M | 4.757 M | 4.673 M | 4.709 M | 4.884 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 451.219 M | 441.850 M | 450.430 M | 451.054 M | 442.337 M | 454.642 M | 455.227 M | 336.557 M | |
| Total liabilities | 272.220 M | 260.655 M | 265.035 M | 261.584 M | 251.739 M | 270.967 M | 275.057 M | 275.668 M | |
| Total current liabilities | 93.343 M | 82.377 M | 87.319 M | 73.709 M | 64.057 M | 76.937 M | 222.887 M | 70.566 M | |
| Accounts Payable | 30.461 M | 23.328 M | 36.392 M | 24.593 M | 22.813 M | 22.784 M | 19.514 M | 20.667 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 141.421 M | 0.000 | |
| Long term debt | 141.800 M | 141.928 M | 142.057 M | 142.185 M | 142.312 M | 148.994 M | 7.475 M | 160.694 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 178.999 M | 181.195 M | 185.395 M | 189.470 M | 190.598 M | 183.675 M | 180.170 M | 60.889 M | |
| Common stock | 61.905 M | 62.204 M | 62.388 M | 62.575 M | 62.838 M | 63.149 M | 63.321 M | 63.488 M | |
| Retained earnings | -429.813 M | -430.969 M | -430.508 M | -430.817 M | -432.910 M | -442.419 M | -448.767 M | -571.871 M |